Guangji Pharmaceutical: Plans to list and transfer 49% equity of Changtou Anhua Hotel

Guangji Pharmaceutical announced that the company plans to publicly list for transfer its 49% equity interest in Hubei Changtou Anhua Hotel Co., Ltd. on the Wuhan Optics Valley United Property Rights Exchange, with a listing price of no less than the filed appraised value of the corresponding equity of RMB 22.1378 million. After the transaction is completed, the company will no longer hold any shares in Changtou Anhua Hotel. Changjiang Asset Management, a wholly-owned subsidiary of the company's controlling shareholder Changjiang Industrial Group, intends to participate in the bidding, and this transaction may constitute a related-party transaction. The matter has been approved by the company's board of directors, does not need to be submitted to the shareholders' meeting for review, and does not constitute a major asset restructuring.